SCHEMBL3659008

SCHEMBL3659008

CCCCOC(=O)Nc1ccccc1C(CC)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.57
CYP1A2 P05177 3/20 0.57
CYP2C19 P33261 3/20 0.57
ALDH1A1 P00352 6/20 0.51
NLRP3 Q96P20 1/20 0.47
RAB9A P51151 9/20 0.47
NPC1 O15118 8/20 0.47
HPGD P15428 5/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
KDM4E B2RXH2 2/20 0.45
LMNA P02545 3/20 0.45
NFKB1 P19838 1/20 0.44
STAT1 P42224 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
CASP1 P29466 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
MCL1 Q07820 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3655574 0.86 SMN1; SMN2 (0.59) SMN1; SMN2CYP1A2CYP2C19ALDH1A1NLRP3
SCHEMBL3867996 0.79 SMN1; SMN2 (0.68) SMN1; SMN2CYP1A2CYP2C19ALDH1A1RAB9A
SCHEMBL8068696 0.79 SMN1; SMN2 (0.54) SMN1; SMN2CYP1A2CYP2C19ALDH1A1NLRP3
SCHEMBL5086243 0.79 SMN1; SMN2 (0.53) SMN1; SMN2CYP1A2CYP2C19ALDH1A1NLRP3
SCHEMBL28513102 0.78 TSHR (0.55) SMN1; SMN2CYP2C19ALDH1A1RAB9ANPC1
SCHEMBL8067585 0.77 SMN1; SMN2 (0.52) SMN1; SMN2CYP1A2CYP2C19ALDH1A1NLRP3
SCHEMBL2320061 0.77 SMN1; SMN2 (0.77) SMN1; SMN2CYP1A2CYP2C19ALDH1A1RAB9A
SCHEMBL13506223 0.76 SMN1; SMN2 (0.68) SMN1; SMN2CYP1A2CYP2C19ALDH1A1RAB9A
SCHEMBL7378894 0.76 SMN1; SMN2 (0.68) SMN1; SMN2CYP1A2CYP2C19ALDH1A1RAB9A
SCHEMBL10489645 0.76 SMN1; SMN2 (0.53) SMN1; SMN2CYP1A2CYP2C19ALDH1A1NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234982-A1 SUBSTITUTED HYDANTOINS AS MEK KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009080523-A1 SUBSTITUTED HYDANTOINS AS MEK KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-07-02 WO disclosed
WO-2008101840-A1 COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-28 WO disclosed